Autologous haematopoietic stem cell transplantation has been used to stop autoimmune processes in MS, although the treatment is not effective for every person.
Fortunately, research is always evolving and there is now an improved version of the technique which is showing extremely good results, with patients free of both the need for treatment and the risk of relapses for years on end — but the risk associated with the procedure is substantial.
What are the risks for MS patients and how does this treatment work? The current stem cell transplantation process for these patients involves stem cells being collected from their own bone marrow before the patients are exposed to chemotherapy. This treatment suppresses the immune system, so that when the stem cells are injected back into a person, the immune system is reset to no longer attack the body.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.